Reply - 06/08/18
Doi : 10.1016/j.ajog.2018.05.015
Sukhbir S. Singh, MD 
Department of Obstetrics, Gynecology, and Newborn Care, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Liane Belland, MSc, MD, FRCSC
Department of Obstetrics and Gynecology, University of Calgary, Calgary, Alberta, Canada
Nicholas Leyland, MD, MHCM, FRCSC
Department of Obstetrics and Gynecology Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
Ally Murji, MD, MPH, FRCSC
Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Monday 06 August 2018
Le texte complet de cet article est disponible en PDF.
| For the original article, Allergan Canada provided financial support for editorial assistance by the medical writer (S.v.R.). The sponsor did not have any input into the collection, analysis, and interpretation of data, or into the clinical recommendations and other content of this article. |
|
| Disclosure: S.S.S. has research grants with Abbvie, Bayer, and Allergan. He has been a consultant and speaker for Abbvie, Bayer, and Allergan. L.B. has been part of national advisory boards for Allergan and Abbvie. She has been part of speakers’ bureaus for Allergan, Abbvie, and Bayer. N.L. has received research grant support from Allergan, Bayer, and Abbvie. S.v.R. is a full-time employee of SCRIPT, a third-party medical communications agency. SCRIPT received funding from Allergan Canada (as above) for the preparation of the original manuscript. A.M. has been part of the speakers’ bureaus and advisory boards for Abbvie, Allergan, Bayer, and Hologic. |
© 2018
Elsevier Inc. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?